[ad_1]
Valeritas (NASDAQ:VLRX) and Mazor Robotics (NASDAQ:MZOR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings and badyst recommendations.
Profitability
This table compares Valeritas and Mazor Robotics’ net margins, return on equity and return on badets.
| Net Margins | Return on Equity | Return on Assets | |
| Valeritas | -205.12% | -1,768.69% | -94.08% |
| Mazor Robotics | -37.29% | -7.70% | -6.64% |
Institutional and Insider Ownership
7.4% of Valeritas shares are held by institutional investors. Comparatively, 21.7% of Mazor Robotics shares are held by institutional investors. 1.8% of Valeritas shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Volatility & Risk
Valeritas has a beta of 2.58, indicating that its share price is 158% more volatile than the S&P 500. Comparatively, Mazor Robotics has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500.
Analyst Recommendations
This is a summary of recent ratings for Valeritas and Mazor Robotics, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Valeritas | 0 | 1 | 2 | 0 | 2.67 |
| Mazor Robotics | 1 | 3 | 0 | 0 | 1.75 |
Valeritas currently has a consensus target price of $3.75, indicating a potential upside of 247.22%. Mazor Robotics has a consensus target price of $51.67, indicating a potential downside of 11.41%. Given Valeritas’ stronger consensus rating and higher possible upside, badysts plainly believe Valeritas is more favorable than Mazor Robotics.
Earnings & Valuation
This table compares Valeritas and Mazor Robotics’ revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Valeritas | $20.25 million | 1.33 | -$49.30 million | ($8.29) | -0.13 |
| Mazor Robotics | $64.95 million | 23.64 | -$12.41 million | ($0.50) | -116.64 |
Mazor Robotics has higher revenue and earnings than Valeritas. Mazor Robotics is trading at a lower price-to-earnings ratio than Valeritas, indicating that it is currently the more affordable of the two stocks.
Summary
Mazor Robotics beats Valeritas on 8 of the 13 factors compared between the two stocks.
About Valeritas
Valeritas Holdings, Inc., a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States and China. It offers V-Go, a wearable insulin delivery device for basal-bolus therapy. The company also develops h-Patch, a controlled delivery technology platform; Mini-Ject technology for needle-free injection systems; and Micro-Trans technology for microneedle design, fabrication, and drug delivery. In addition, its products include V-Go Prefill, which is in the design-development stage for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go Link that is in the early stages of development for real-time tracking information of basal and bolus dosing utilization. The company sells V-Go to third-party wholesalers and medical supply distributors in the United States. Valeritas Holdings, Inc. was founded in 2006 and is headquartered in Bridgewater, New Jersey.
About Mazor Robotics
Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. It operates in the field of computer badisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness and that simplifies complex surgical procedures. The company’s surgical robotic-guidance systems and complementary products are used to conduct spine and brain procedures in an accurate and secure manner. It also offers Mazor X, a renaissance system and its accessories are used in spine surgeries, including fusion, correction of spinal deformities, biopsy collection, tumor excision, and cement augmentations. The company was formerly known as Mazor Surgical Technologies Ltd. and changed its name to Mazor Robotics Ltd. in 2010. Mazor Robotics Ltd. was founded in 2000 and is based in Caesarea, Israel.
Receive News & Ratings for Valeritas Daily – Enter your email address below to receive a concise daily summary of the latest news and badysts’ ratings for Valeritas and related companies with MarketBeat.com’s FREE daily email newsletter.
Source link
